Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY (DEFICIT)

v3.19.3
STOCKHOLDERS' EQUITY (DEFICIT)
9 Months Ended
Sep. 30, 2019
Equity [Abstract]  
STOCKHOLDERS' EQUITY (DEFICIT)

NOTE 12. STOCKHOLDERS’ EQUITY (DEFICIT)

During the nine months ended September 30, 2019, we issued an aggregate of 229,200 restricted shares of our common stock valued at $388,919, to our board members in consideration of their service on the Board. These shares vested immediately on the grant date.  

On May 6, 2019, we redeemed all 23,271,667 shares of our common stock held by Triangulum.